FDA Approves J&J’s Navistar ThermoCool For Atrial Fibrillation Ablation
This article was originally published in The Gray Sheet
Executive Summary
With PMA approval Feb. 6, Johnson & Johnson/Biosense Webster's NaviStar ThermoCool and EZ Steer ThermoCool Navigational became the first cardiac ablation catheters approved by FDA specifically for treatment of atrial fibrillation
You may also be interested in...
CardioFocus Piles Up Data On HeartLight Laser AF Ablation Catheter
In addition to the more than 1,300 ablation procedures completed outside the U.S. with the unique visually guided ablation catheter, the venture-backed company is conducting an IDE trial in 21 U.S. centers, which it expects to complete in 2014.
CardioFocus Piles Up Data On HeartLight Laser AF Ablation Catheter
In addition to the more than 1,300 ablation procedures completed outside the U.S. with the unique visually guided ablation catheter, the venture-backed company is conducting an IDE trial in 21 U.S. centers, which it expects to complete in 2014.
Medtronic STOP AF Results Show Efficacy, But Raise Some Safety Concerns
Results of Medtronic's STOP AF trial show that 69.3% of patients treated with its Arctic Front cryoballoon catheter were free from atrial fibrillation at one year